Immune sensitization and mortality in wait-listed kidney transplant candidates

Journal of the American Society of Nephrology

Volumn 27, Issue 2, 2016, Pages 570-578

  Sapir Pichhadze, Ruth ^a,b,c   Tinckam, Kathryn J ^a,c,d   Laupacis, Andreas ^a,e   Logan, Alexander G ^a,b,c   Beyene, Joseph ^b,f,g   Kim, S Joseph ^a,b,c,h  

^a TORONTO GENERAL HOSPITAL   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c Department of Medicine   (Canada)

^d UNIVERSITY OF TORONTO   (Canada)

^e ST MICHAEL'S HOSPITAL   (Canada)

^f ST MICHAEL'S HOSPITAL   (Canada)

^g HOSPITAL FOR SICK CHILDREN   (Canada)

^h MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

HLA ANTIBODY; PANEL REACTIVE ANTIBODY; HLA ANTIGEN;

ADULT; ARTICLE; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; COMORBIDITY; DIABETES MELLITUS; END STAGE RENAL DISEASE; FEMALE; HEMODIALYSIS; HUMAN; HYPERTENSION; KIDNEY GRAFT; MAJOR CLINICAL STUDY; MALE; OBESITY; PERIPHERAL VASCULAR DISEASE; PERITONEAL DIALYSIS; PRIORITY JOURNAL; RISK ASSESSMENT; BLOOD; CARDIOVASCULAR DISEASES; COHORT ANALYSIS; COMPLICATION; HOSPITAL ADMISSION; IMMUNOLOGY; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; MIDDLE AGED; MORTALITY; PREDICTIVE VALUE; RETROSPECTIVE STUDY;

CARDIOVASCULAR DISEASES; COHORT STUDIES; FEMALE; HLA ANTIGENS; HUMANS; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; WAITING LISTS;

EID: 84970937464     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2014090894     Document Type: Article

References (41)

1. US Renal Data System: Mortality. In: 2013 USRDS Annual Data Report, Bethesda, MD, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 2013, pp 263-270
2. US Department of Health and Human Services, Health Resources and Services Administration: Kidney. In: OPTN/SRTR 2011 Annual Data Report, Rockville, MD, US Department of Health and Human Services, Health Resources and Services Administration, 2012, pp 11-46
3. Longenecker JC, Coresh J, Powe NR, Levey AS, FinkNE, Martin A, Klag MJ: Traditional cardiovascular disease risk factors in dialysis patients compared with the general population: The CHOICE Study. J Am Soc Nephrol 13: 1918-1927, 2002
4. Yeun JY, Levine RA, Mantadilok V, Kaysen GA: C-reactive protein predicts all-cause and cardiovascularmortality in hemodialysis patients. AmJ Kidney Dis 35: 469-476, 2000
5. Wanner C, Zimmermann J, Schwedler S, Metzger T: Inflammation and cardiovascular risk in dialysis patients. Kidney Int Suppl 80: 99-102, 2002
6. Kasal DA, Barhoumi T, Li MW, Yamamoto N, Zdanovich E, Rehman A, Neves MF, Laurant P, Paradis P, Schiffrin EL: T regulatory lymphocytes prevent aldosterone-induced vascular injury. Hypertension 59: 324-330, 2012
7. Schiffrin EL: Immune mechanisms in hypertension and vascular injury. Clin Sci (Lond) 126: 267-274, 2014
8. Patel RK, Arya R: Does IgA antibody against b2 glycoprotein I increase cardiovascular risk in hemodialysis patients? Kidney Int 81: 1164-1166, 2012
9. Meier-Kriesche HU, Schold JD, Srinivas TR, Reed A, Kaplan B: Kidney transplantation halts cardiovascular disease progression in patients with end-stage renal disease. Am J Transplant 4: 1662-1668, 2004
10. Katznelson S, Bhaduri S, Cecka JM Clinical aspects of sensitization. Clin Transpl 285-296, 1997
11. Barama A, Oza U, Panek R, Belitsky P, MacDonald AS, Lawen J, McAlister V, Kiberd B: Effect of recipient sensitization (peak PRA) on graft outcome in haploidentical living related kidney transplants. Clin Transplant 14: 212-217, 2000
12. Gebel HM, Bray RA, Nickerson P: Pre-transplant assessment of donorreactive, HLA-specific antibodies in renal transplantation: Contraindication vs. risk. Am J Transplant 3: 1488-1500, 2003
13. Tambur AR, Leventhal JR, Walsh RC, Zitzner JR, Friedewald JJ: HLADQ barrier: Effects on cPRA calculations. Transplantation 96: 1065-1072, 2013
14. Chang P, Gill J, Dong J, Rose C, Yan H, Landsberg D, Cole EH, Gill JS: Living donor age and kidney allograft half-life: Implications for living donor paired exchange programs. Clin J Am Soc Nephrol 7: 835-841, 2012
15. Hill GS, Nochy D, Bruneval P, Duong van Huyen JP, Glotz D, Suberbielle C, Zuber J, Anglicheau D, Empana JP, Legendre C, Loupy A: Donor-specific antibodies accelerate arteriosclerosis after kidney transplantation. J AmSoc Nephrol 22: 975-983, 2011
16. Hansson GK, Hermansson A: The immune system in atherosclerosis. Nat Immunol 12: 204-212, 2011
17. Barhoumi T, Kasal DA, LiMW, Shbat L, Laurant P, Neves MF, Paradis P, Schiffrin EL: T regulatory lymphocytes prevent angiotensin II-induced hypertension and vascular injury. Hypertension 57: 469-476, 2011
18. Parikh NI, Cnattingius S, Dickman PW, Mittleman MA, Ludvigsson JF, Ingelsson E: Parity and risk of later-lifematernal cardiovascular disease. Am Heart J 159: 215. e216-221. e216, 2010
19. Steenland K, Lally C, ThunM: Parity and coronary heart disease among women in the American Cancer Society CPS II population. Epidemiology 7: 641-643, 1996
20. Hinkula M, Kauppila A, Näyhä S, Pukkala E: Cause-specific mortality of grand multiparous women in Finland. Am J Epidemiol 163: 367-373, 2006
21. Koski-Rahikkala H, Pouta A, Pietiläinen K, Hartikainen AL: Does parity affect mortalityamong parouswomen? J Epidemiol CommunityHealth 60: 968-973, 2006
22. Jacobsen BK, Knutsen SF, Oda K, Fraser GE: Parity and total, ischemic heart disease and stroke mortality. The Adventist Health Study, 1976-1988. Eur J Epidemiol 26: 711-718, 2011
23. Jacobs MB, Kritz-Silverstein D, Wingard DL, Barrett-Connor E: The association of reproductive history with all-cause and cardiovascular mortality in older women: The Rancho Bernardo Study. Fertil Steril 97: 118-124, 2012
24. Simons LA, Simons J, Friedlander Y, McCallum J: Childbearing history and late-life mortality: The Dubbo study of Australian elderly. Age Ageing 41: 523-528, 2012
25. Dior UP, Hochner H, Friedlander Y, Calderon-Margalit R, Jaffe D, Burger A, AvgilM,Manor O, Elchalal U: Association between number of children and mortality of mothers: Results of a 37-year follow-up study. Ann Epidemiol 23: 13-18, 2013
26. Ryan MJ: An update on immune system activation in the pathogenesis of hypertension. Hypertension 62: 226-230, 2013
27. Cecka JM:Calculated PRA (CPRA): The newmeasure of sensitization for transplant candidates. Am J Transplant 10: 26-29, 2010
28. Pei R, Lee JH, Shih NJ, Chen M, Terasaki PI: Single human leukocyte antigen flow cytometry beads for accurate identification of human leukocyte antigen antibody specificities. Transplantation 75: 43-49, 2003
29. Grams ME, Massie AB, Schold JD, Chen BP, Segev DL: Trends in the inactive kidney transplant waitlist and implications for candidate survival. Am J Transplant 13: 1012-1018, 2013
30. Leppke S, Leighton T, ZaunD, Chen SC, SkeansM, Israni AK, Snyder JJ, Kasiske BL: Scientific Registry of Transplant Recipients: Collecting, analyzing, and reporting data on transplantation in the United States. Transplant Rev (Orlando) 27: 50-56, 2013
31. US Centers for Disease Control and Prevention: NCHS-CMS Medicare and NCHS-USRDS linked data. Available at: http://www. cdc. gov/nchs/data/datalinkage/description-of-nchs-cms-medicare-linkage-final. pdf. Accessed February 12, 2014
32. Rocco MV, Yan G, Gassman J, Lewis JB, Ornt D, Weiss B, Levey AS: Comparison of causes of death using HEMO Study and HCFA endstage renal disease death notification classification systems. The National Institutes of Health-funded Hemodialysis. Health Care Financing Administration. AmJ Kidney Dis 39: 146-153, 2002
33. Snappin S, Jiang Q, Iglewicz B: Illustrating the impact of a time-varying covariate with an extended Kaplan-Meier estimator. Am Stat 59: 301-307, 2005
34. Huber PJ: The behavior of maximum likelihood estimates under nonstandard conditions. In: Proceedings of the Fifth Berkeley Symposium on Mathematical Statistics and Probability, Berkeley, CA, University of California Press, 1967, pp 221-233
35. Rogers WH: Regression standard errors in clustered samples. Stata Tech Bull 13: 19-23, 1993
36. Gutierrez RG: Parametric frailty and shared frailty survival models. Stata J 2: 22-44, 2002
37. Royston P, Sauerbrei W: Multivariable Model-Building: A Pragmatic Approach to Regression Analysis Based on Fractional Polynomials for Modelling Continuous Variables. Chichester, UK, John Wiley & Sons, Ltd, 2008
38. Smits JM, van Houwelingen HC, De Meester J, Persijn GG, Claas FH: Analysis of the renal transplant waiting list: Application of a parametric competing risk method. Transplantation 66: 1146-1153, 1998
39. Fine JP, Gray RJ: A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc 94: 496-509, 1999
40. von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP; STROBE Initiative: The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: Guidelines for reporting observational studies. Lancet 370: 1453-1457, 2007
41. Dafni U: Landmark analysis at the 25-year landmark point. Circ Cardiovasc Qual Outcomes 4: 363-371, 2011